 "dr reddy's laboratory , dr reddy , drl pharma sector")
Indian generic drugmaker Dr Reddy's Laboratories reported a second-quarter profit that missed analysts' expectations on Tuesday, weighed down by pricing pressure in a competitive North American market, their biggest by revenue.
The company reported a 9.5 per cent fall in its consolidated net profit after tax to Rs 1,342 crore ($159.6 million) for the quarter ended Sept. 30, missing analysts' estimate of Rs 1,401 crore, as per data compiled by LSEG.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
 "Dr Reddy's Laboratories")
 "UEFA Champions League")
 "S Jaishankar, Jaishankar, Richard Marles")
 "Fiscal deficit")
